3-(4-(Benzyloxy)-3-methoxyphenyl)propan-1-ol, 95.0%, 5g

1,1,4,4, Tetramethyl-1,4-disila-5-oxacyclopentane, 97%, 5g

Polyethylene Glycol Mono-4-octylphenyl Ether (n=approx. 10) [for Biochemical Research]5g

3,4-Dichloro-5-fluorobenzaldehyde, 95.0%, 250mg

2-Isobutyl-3,5,6-trimethylpyrazine, 95.0%, 100mg

Fmoc-4-Iodo-D-Phe-OH, >98%, 10g

methyl (5S,8S,10aR)-5-(tert-butoxycarbonylamino)-6-oxo-2,3,4,5,8,9,10,10a-octahydro-1H-pyrrolo[1,2-a][1,5]diazocine-8-carboxylate, 97, 250mg

4,4''-Dibromo-1,1':3',1''-terphenyl, 98%, 100mg

Acide orotique, min 99 %, anhydre, 25 g, emballage plastique.

3-CYCLOPENTYL-1,2-OXAZOL-5-AMINE, 95.0%, 1g

1-(6-BROMO-2-PYRIDYL)ETHYLAMINE, 95.0%, 10g

2'-Bromo-4'-fluoroacetophenone, 98.0%, 10g

1,2,4-Trifluoro-3-iodobenzene, 95.0%, 1g